Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial

BACKGROUND: Infliximab and ciclosporin are of similar efficacy in treating acute severe ulcerative colitis, but there has been no comparative evaluation of their relative clinical effectiveness and cost-effectiveness. METHODS: In this mixed methods, open-label, pragmatic randomised trial, we recruit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Gastroenterol Hepatol
Main Authors: Williams, John G, Alam, M Fasih, Alrubaiy, Laith, Arnott, Ian, Clement, Clare, Cohen, David, Gordon, John N, Hawthorne, A Barney, Hilton, Mike, Hutchings, Hayley A, Jawhari, Aida U, Longo, Mirella, Mansfield, John, Morgan, Jayne M, Rapport, Frances, Seagrove, Anne C, Sebastian, Shaji, Shaw, Ian, Travis, Simon P L, Watkins, Alan
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994668/
https://ncbi.nlm.nih.gov/pubmed/27595142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(16)30003-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados